Where does Coloplast A/S rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Coloplast A/S ranks #791 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Coloplast A/S hold?

Coloplast A/S holds 581 US utility patents granted between 2015 and 2025, spanning 61 technology areas.

What is Coloplast A/S's Innovation Score?

Coloplast A/S has an Innovation Score of 64.9 out of 100 (top 1% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Coloplast A/S's patent grant rate increasing or decreasing?

Coloplast A/S's recent grant velocity is -25% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Coloplast A/S's patents?

Coloplast A/S's patents average 13.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Coloplast A/S patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Coloplast A/S

Q: What technology areas does Coloplast A/S focus on?

Coloplast A/S's top technology area is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs) with 378 patents, ranking #17 of 3,082 assignees active in that subclass. Grants appear in 61 CPC subclasses total.

USPTO PatentsView assignee record - 581 granted patents across 61 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Coloplast ranks #791 of 49,997 tracked US assignees by granted-patent volume, with 581 patents across 61 technology areas.

#791
of 49,997 US assignees by volume: Top 1%
by Innovation Score (64.9/100): 13.3
avg claims per patent: -25%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R791 · Foreign Corporation #791 · 581 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-STRONG · CLAIMS-RICH · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL

GRANTS-MID 581 grants
TOP-DECILE #791/49,997
PHOTO-FINISH University of…
CPC-WIDE A61F · 61 areas
INNOV-STRONG 64.9/100
CLAIMS-RICH 13.3 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DOWN -25% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: University of Central Florida Research Foundation (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Coloplast’s 64.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 22.0 pts (34%) Velocity 9.9 pts (15%) Breadth 25.0 pts (39%) Claim depth 8.0 pts (12%)

Qualcomm Incorporated · highest

85
pSemi · near

65
Aktiebolaget SKF · near

65
Beijing BOE… · near

65
Coloplast A/S · this assignee

65
Schott · near

65
3D Lighting… · lowest

7

What this shows Coloplast's Innovation Score is 64.9/100 (top 1% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Coloplast?

Each dot is one of Coloplast’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Coloplast’s own 13.3 claims/patent is at or below the 15.8 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Coloplast vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

How Coloplast's grant cadence moved

Between 2020–2024, Coloplast A/S received 231 grants versus 310 in 2015–2019 (-25% equal-window velocity, below median growth). Across complete PatentsView years, output peaked in 2017 at 74 grants and bottomed in 2020 at 31. Lead class A61F accounts for 65.1% of the portfolio across 61 subclasses. Volume neighbours: Children's Medical Center Corporation (#787) and The Government of the United States of America, as represented by the Secretary of the Navy (#795).

Coloplast's three-year grant acceleration

From 2019–2021 to 2022–2024, Coloplast A/S moved from 111 to 165 grants (1.49x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #465. See the growth leaderboard.

Children's Medica…

583
Howmedica Osteoni…

583
Analog Devices In…

582
irobot

582
University of Cen…

581
Coloplast A/S ◀

581
Compal

580
Rohr

579
The Government of…

579

What this shows Coloplast holds 581 patents at rank #791, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Coloplast

By rank, the assignees closest to #791 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Coloplast's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Coloplast, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), Coloplast ranks #17 of 3,082 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (65 here).

Aktiebolaget SKF 65 Beijing BOE Optoelectronics Technology Co., Ltd. 65 Schott AG 65 pSemi Corporation 65

Similar claim depth

Nearest assignees by average claims per patent (13.3 here).

Depuy Ireland Unlimited Company 13.3 avg Institute for Cancer Research 13.3 avg MANN+HUMMEL GmbH 13.3 avg B/E Aerospace, Inc. 13.3 avg

Coloplast's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

65 Top 1% higher than 99% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Coloplast A/S patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	73	12.6%
2016	57	9.8%
2017	74	12.7%
2018	61	10.5%
2019	45	7.7%
2020	31	5.3%
2021	35	6.0%
2022	45	7.7%
2023	62	10.7%
2024	58	10.0%
2025partial year	40	6.9%

Which technologies does Coloplast A/S patent most?

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 378

A61B - DIAGNOSIS; SURGERY; Identification 172

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 87

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 51

C08G - Macromolecular Compounds Obtained Otherwise Than BY Reactions Only Involving Unsaturated Carbon-to-carbon Bonds 19

C08F - Macromolecular Compounds Obtained BY Reactions Only Involving Carbon-to-carbon Unsaturated Bonds 17

C08L - Compositions OF Macromolecular Compounds 15

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 13

Y10T - Technical Subjects Covered BY Former US Classification 13

C08J - WORKING-UP; General Processes OF COMPOUNDING; After-treatment NOT Covered BY Subclasses C08b, C08c, C08f, C08g or C08h 11

B65D - Containers FOR Storage OR Transport OF Articles OR Materials, e.g. Bags, Barrels, Bottles, Boxes, Cans, Cartons, Crates, Drums, Jars, Tanks, Hoppers, Forwarding CONTAINERS; Accessories, Closures, OR Fittings THEREFOR; Packaging ELEMENTS; Packages 11

B29C - Shaping OR Joining OF PLASTICS; Shaping OF Material IN A Plastic State, NOT Otherwise Provided FOR; After-treatment OF THE Shaped Products, e.g. Repairing 10

C07C - Acyclic OR Carbocyclic Compounds 10

B29L - Indexing Scheme Associated With Subclass B29c, Relating TO Particular Articles 9

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 8

Top 15 of 61 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Coloplast A/S's patent record in context - here's where to go next.

Coloplast A/S's lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 65.1% of its portfolio - see every assignee active in that class. Explore A61F
Ranked #791 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Coloplast A/S against Children's Medical Center Corporation, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 64.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.